Malaga Cove Capital, LLC Repligen Corp Transaction History

Malaga Cove Capital, LLC

  • $236 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$120.0 - $182.95 $173,760 - $264,911
1,448 Added 32.48%
5,906 $744,000
Q4 2023

Feb 06, 2024
BUY
$114.17 - $185.35 $223,887 - $363,471
1,961 Added 78.53%
4,458 $801,000
Q2 2023

Aug 02, 2023
BUY
$138.42 - $180.31 $345,634 - $450,234
2,497 New
2,497 $353,000

Others Institutions Holding RGEN

# of Institutions
486
Shares Held
54.3M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.71B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Malaga Cove Capital, LLC Portfolio

Follow Malaga Cove Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Malaga Cove Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email